Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus

Joy Cuthberston, Steven Patterson, Finbarr O'Harte, Patrick Bell

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences